WELL Health and HEALWELL AI launch consent‑first research platform
WELL Health and HEALWELL AI launched WELLTRUST, a consent-first research platform that combines HEALWELL’s DARWEN AI with WELL’s outpatient clinic network to identify patients who opt into trial contact in a privacy-preserving, regulatory-compliant way, initially targeting chronic, rare and complex conditions across Canada.
Why it mattersDARWEN AI-enabled matching across WELL's outpatient clinic network lets sponsors accelerate recruitment for chronic and aging-focused trials.